| scholarly article | Q13442814 |
| P2093 | author name string | D K Hsu | |
| F T Liu | |||
| I Kuwabara | |||
| W R Henderson | |||
| E Y Chi | |||
| R I Zuberi | |||
| P2860 | cites work | Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain | Q24316043 |
| Molecular cloning of a human macrophage lectin specific for galactose | Q24324589 | ||
| Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms | Q24324705 | ||
| Galectins. Structure and function of a large family of animal lectins | Q28246794 | ||
| Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor | Q28301754 | ||
| Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells | Q28572966 | ||
| Expression of biologically active recombinant rat IgE-binding protein in Escherichia coli | Q28573279 | ||
| Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts | Q34345937 | ||
| An IgE-binding protein with a distinctive repetitive sequence and homology with an IgG receptor | Q34350389 | ||
| The mannose receptor and other macrophage lectins | Q35228669 | ||
| Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein. | Q35273287 | ||
| The Mac-2 antigen is a galactose-specific lectin that binds IgE. | Q35596399 | ||
| Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets | Q35885481 | ||
| Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane | Q36229800 | ||
| Eosinophil peroxidase-induced mast cell secretion | Q36343960 | ||
| Oxidative degradation of leukotriene C4 by human monocytes and monocyte-derived macrophages | Q36351166 | ||
| Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation | Q36361158 | ||
| Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism | Q36383370 | ||
| Hydrogen peroxide metabolism in human monocytes during differentiation in vitro | Q37005256 | ||
| Identification of an IgE-binding protein by molecular cloning | Q37691712 | ||
| Lectins as cell recognition molecules | Q38294576 | ||
| S-type mammalian lectins in allergic inflammation | Q38315519 | ||
| Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin | Q38327495 | ||
| Soluble lactose-binding vertebrate lectins: a growing family | Q38343078 | ||
| Binding of activated macrophages to tumor cells through a macrophage lectin and its role in macrophage tumoricidal activity | Q38344405 | ||
| The Cell Biology of Macrophage Activation | Q40081110 | ||
| Defect in Pyridine Nucleotide Dependent Superoxide Production by a Particulate Fraction from the Granulocytes of Patients with Chronic Granulomatous Disease | Q40335022 | ||
| Mac-2: a versatile galactose-binding protein of mammalian tissues | Q40754202 | ||
| Structure of baby hamster kidney carbohydrate-binding protein CBP30, an S-type animal lectin | Q41455397 | ||
| Control of Mac-2 surface expression on murine macrophage cell lines | Q41501118 | ||
| Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. Evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway | Q41548079 | ||
| Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages | Q41641013 | ||
| Secretion of the baby hamster kidney 30-kDa galactose-binding lectin from polarized and nonpolarized cells: a pathway independent of the endoplasmic reticulum-Golgi complex | Q42505508 | ||
| Oxidative degradation of rat mast-cell heparin proteoglycan | Q42859290 | ||
| Murine macrophage cell lines can be ordered in a linear differentiation sequence | Q44786272 | ||
| Activation of rat basophilic leukemia cells by epsilon BP, an IgE-binding endogenous lectin | Q46095556 | ||
| Galectins: a family of animal beta-galactoside-binding lectins | Q48084852 | ||
| Carbohydrate binding protein 35. Complementary DNA sequence reveals homology with proteins of the heterogeneous nuclear RNP | Q48324182 | ||
| Purification and characterization of a lectin-like molecule specific for galactose/N-acetyl-galactosamine from tumoricidal macrophages | Q68058242 | ||
| Kinetic microplate assay for superoxide production by neutrophils and other phagocytic cells | Q68484796 | ||
| The major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2) | Q68768239 | ||
| Quantitative immunocytochemical characterization of mononuclear phagocytes. I. Monoblasts, promonocytes, monocytes, and peritoneal and alveolar macrophages | Q68985742 | ||
| A method of trace iodination of proteins for immunologic studies | Q70063670 | ||
| Isolation and physicochemical characterization of electrolectin, a beta-D-galactoside binding lectin from the electric organ of Electrophorus electricus | Q70797489 | ||
| A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils | Q72646571 | ||
| IgE-binding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity | Q72650452 | ||
| Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages | Q72772895 | ||
| Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer | Q72940056 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1016-1028 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages | |
| P478 | volume | 147 |
| Q57824492 | A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy |
| Q79451713 | A role for galectin-3 in CD13-mediated homotypic aggregation of monocytes |
| Q42223040 | Activated Microglia Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine Kinase |
| Q34122713 | Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans |
| Q34052231 | Allergen-induced airway remodeling is impaired in galectin-3-deficient mice |
| Q41226076 | Astrocyte reactivity after brain injury-: The role of galectins 1 and 3. |
| Q55460211 | Bone marrow-derived mesenchymal stem/stromal cells reverse the sensorial diabetic neuropathy via modulation of spinal neuroinflammatory cascades. |
| Q88251046 | C. elegans-based screen identifies lysosome-damaging alkaloids that induce STAT3-dependent lysosomal cell death |
| Q38879889 | CD13 mediates phagocytosis in human monocytic cells |
| Q33646444 | CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung |
| Q27863426 | Characterization of inflammatory gene expression and galectin-3 function after spinal cord injury in mice |
| Q35103551 | Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma |
| Q35169042 | Critical role of galectin-3 in phagocytosis by macrophages |
| Q35208137 | Decay-accelerating factor 1 deficiency exacerbates leptospiral-induced murine chronic nephritis and renal fibrosis. |
| Q42072739 | Detection of galectin-3 in tear fluid at disease states and immunohistochemical and lectin histochemical analysis in human corneal and conjunctival epithelium. |
| Q38942488 | Effect of galectin-3 on the behavior of Eca‑109 human esophageal cancer cells |
| Q29347292 | Eosinophil-expressed galectin-3 regulates cell trafficking and migration |
| Q37823854 | Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity |
| Q36862621 | Expression of galectin-3 as a testis inflammatory marker in vasectomised mice |
| Q24309392 | Expression of galectin-3 modulates T-cell growth and apoptosis |
| Q83167907 | Expression of galectins-1, -3 and -4 varies with strain and type of experimental colitis in mice |
| Q35646647 | Extracellular functions of galectin-3. |
| Q36101399 | Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation |
| Q35931701 | Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation |
| Q64094882 | Galectin-3 Inhibits Paracoccidioides brasiliensis Growth and Impacts Paracoccidioidomycosis through Multiple Mechanisms |
| Q90152813 | Galectin-3 Is a Potential Mediator for Atherosclerosis |
| Q40239271 | Galectin-3 Is a Target for Proteases Involved in the Virulence of Staphylococcus aureus |
| Q35646658 | Galectin-3 and metastasis |
| Q49400435 | Galectin-3 and the incidence of abdominal aortic aneurysm: the atherosclerosis risk in communities (ARIC) study |
| Q36326176 | Galectin-3 as a Potential Target to Prevent Cancer Metastasis. |
| Q37111813 | Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells |
| Q24649584 | Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis |
| Q35765442 | Galectin-3 expression in human atherosclerotic lesions. |
| Q84796426 | Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells |
| Q38336010 | Galectin-3 gene (LGALS3) +292C allele is a genetic predisposition factor for rheumatoid arthritis in Taiwan. |
| Q36357458 | Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice |
| Q47164046 | Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects |
| Q45091985 | Galectin-3 in cord blood of term and preterm infants |
| Q35809815 | Galectin-3 induces endothelial cell morphogenesis and angiogenesis |
| Q44426645 | Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure |
| Q37150796 | Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis |
| Q92377188 | Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease |
| Q42046253 | Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. |
| Q36607267 | Galectin-3 regulates the innate immune response of human monocytes |
| Q36003071 | Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies |
| Q35026202 | Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis |
| Q48159180 | Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. |
| Q34626339 | Galectin-3: a potential target for cancer prevention. |
| Q48731960 | Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas |
| Q27023534 | Galectin-3: its role in asthma and potential as an anti-inflammatory target |
| Q35646669 | Galectins as inflammatory mediators |
| Q35646697 | Galectins in kidney development |
| Q35646679 | Galectins in parasite infection and allergic inflammation. |
| Q64059939 | Galectins in the Pathogenesis of Cerebrovascular Accidents: An Overview |
| Q37457505 | Galectins in the Pathogenesis of Rheumatoid Arthritis |
| Q36381046 | Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages |
| Q37021079 | Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production |
| Q42805774 | Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance. |
| Q35773680 | Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3 |
| Q38007829 | IgE and mast cells in allergic disease |
| Q92106108 | Immune Profile in Blood Following Non-convulsive Epileptic Seizures in Rats |
| Q37137360 | Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines |
| Q46888131 | Immunohistochemical and in situ hybridization analysis of galectin-3, a beta-galactoside binding lectin, in the urinary system of adult mice |
| Q34114819 | Interferon-inducible effector mechanisms in cell-autonomous immunity |
| Q33229810 | Investigation of early protein changes in the urinary bladder following partial bladder outlet obstruction by proteomic approach |
| Q51674074 | Investigation of inflammatory and hemostatic parameters in female patients undergoing total knee arthroplasty surgery. |
| Q33900663 | Lack of galectin-3 disturbs mesenteric lymph node homeostasis and B cell niches in the course of Schistosoma mansoni infection. |
| Q39518249 | Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe |
| Q77394043 | Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice |
| Q34613755 | Mast cells. Receptors, secretagogues, and signaling |
| Q41840818 | Metabotropic glutamate receptor 5 may be involved in macrophage plasticity |
| Q36122424 | Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. |
| Q36937939 | Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxia |
| Q33873592 | Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury |
| Q36617730 | Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. |
| Q37156870 | Monocyte Migration Driven by Galectin-3 Occurs through Distinct Mechanisms Involving Selective Interactions with the Extracellular Matrix |
| Q36885706 | Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis. |
| Q34500864 | Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. |
| Q24307907 | Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling |
| Q38936511 | Pathobiology of neutrophil-epithelial interactions |
| Q26861380 | Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy |
| Q40060474 | Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease |
| Q30841381 | Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy |
| Q99565582 | Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling |
| Q45232856 | Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase |
| Q39377433 | Regulation of Eosinophil Recruitment and Activation by Galectins in Allergic Asthma |
| Q43164816 | Regulation of tumor progression by extracellular galectin-3. |
| Q35969291 | Role of galectin-3 in acetaminophen-induced hepatotoxicity and inflammatory mediator production |
| Q36456913 | Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication |
| Q35646673 | Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity |
| Q35646664 | Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses. |
| Q35491143 | Soluble IgE receptors--elements of the IgE network |
| Q36844332 | Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis |
| Q35809897 | Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. |
| Q33760199 | The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens. |
| Q92130499 | The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children |
| Q37791013 | The Road Less Traveled: Regulation of Leukocyte Migration Across Vascular and Lymphatic Endothelium by Galectins |
| Q39978867 | The bone marrow compartment is modified in the absence of galectin-3 |
| Q89498378 | The oligosaccharides 6'-sialyllactose, 2'-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation |
| Q92474328 | The relationship between galectin-3 levels and fragmented QRS (fQRS) in patients with heart failure with reduced left ventricular ejection fraction |
| Q34226867 | The role of Galectin-1 and Galectin-3 in the mucosal immune response to Citrobacter rodentium infection |
| Q55023271 | The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. |
| Q36838457 | The role of galectin-3 in cancer drug resistance |
| Q36807927 | The role of galectin-3 in phagocytosis of Candida albicans and Candida parapsilosis by human neutrophils |
| Q28261890 | The roles of Galectin-3 in autoimmunity and tumor progression |
| Q39779199 | The spleen as an extramedullary source of inflammatory cells responding to acetaminophen-induced liver injury |
| Q30599520 | Therapeutic inducers of the HSP70/HSP110 protect mice against traumatic brain injury |
| Q35088408 | Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity |
| Q98944112 | Trichinella spiralis co-infection exacerbates Plasmodium berghei malaria-induced hepatopathy |
| Q38772945 | Unconventional Pathways of Secretion Contribute to Inflammation. |
| Q37209184 | Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages |
| Q36196146 | When galectins recognize glycans: from biochemistry to physiology and back again |
| Q33758493 | Why anti-Bcl-2 clinical trials fail: a solution |
Search more.